Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.
about
A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infectionDiagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-AnalysisEvaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study.High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study.Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumoniaThe ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injuryLipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant?New approaches to sepsis: molecular diagnostics and biomarkers.IL6 trans-signaling promotes functional recovery of hypofunctional phagocytes through STAT3 activation during peritonitis.Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patientsTransient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective studyUse of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infeA comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study.Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency departmentRole of biomarkers in sepsis care.Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis.Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health.Rapid diagnosis of sepsis.Procalcitonin in liver transplant patients--yet another stone turned.Pathogenesis analysis of pituitary adenoma based on gene expression profiling.Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies.Procalcitonin: present and future.Diagnostic accuracy of lipopolysaccharide-binding protein for sepsis in patients with suspected infection in the emergency department.Monitoring of procalcitonin but not interleukin-6 is useful for the early prediction of anastomotic leakage after colorectal surgery.Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department.Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis?Prognostic Value and Daily Trend of Interleukin-6, Neutrophil CD64 Expression, C-Reactive Protein and Lipopolysaccharide-Binding Protein in Critically Ill Patients: Reliable Predictors of Outcome or Not?Biomarkers of sepsis.Infection surveillance in transsphenoidal pituitary surgery - comparison of lipopolysaccharide-binding-protein, interleukin 6, C-reactive protein, white blood cell count, erythrocyte sedimentation rate and body temperature.Clinical and laboratory variables identifying bacterial infection and bacteraemia in the emergency department.Effect of Continuous Digital Hypothermia on Lamellar Inflammatory Signaling When Applied at a Clinically-Relevant Timepoint in the Oligofructose Laminitis Model.
P2860
Q24672825-BD2465D7-B063-4246-8A83-84F954546180Q27026668-5B916358-1009-4FFE-ABF7-22EC4A26D16FQ30389765-9FF20512-7773-4974-9D9D-EAD6DD53055DQ33531533-DACB7278-A639-4161-B71E-00AD6EA041FCQ33827245-DD98DBF8-D764-4EFA-92C1-F566FC79C13EQ33945930-D99839BB-E562-47DB-BCFE-BC8FACB1F744Q34013704-2702550B-525A-4C3B-8286-A2CC1C7EBEFCQ34303687-411C01CA-8DB4-4F29-B0B3-455510B2A6A6Q34348389-0F5972E0-B6D3-48B1-94B9-0747D62BDE85Q35070651-FD6AC502-8F83-488A-B551-4F903EA4610BQ36106653-FD21CBBE-8409-467E-8C64-2FC16F9DC6BEQ36197194-D4A8BA48-E6FF-47AF-A50E-E215BCC35C3EQ36392530-7033CDE9-0AB2-44DD-81A4-6D856FBDDEF2Q36392555-AFF5C042-B483-4C1F-9C30-FD32FFCDF882Q36392734-C3EA3FF2-C00D-4006-8DC1-2F22D011FB0CQ36795684-EE13BB34-8C83-4FF8-A0AD-DD96CDD2DE26Q36931182-0733FEA5-B1C1-4062-ABCD-74D7A94E0DD8Q37207285-C5605AFA-A877-4D79-9F1D-D966512DABFAQ37210120-5FCAF484-0D0C-44C1-8C1D-E115B690B9F6Q37249625-E2FCF5DD-FB16-4735-B0EF-63A298D523C5Q37313463-07ECBAFB-D673-46D9-9555-C957F837DA6DQ37496755-5D882A5A-681C-4E29-B2CF-208D660E087DQ38100278-CF5510CA-D5D6-48E5-B6D8-EC9E63A2C07FQ38171058-9C81D61A-98E8-451A-9914-669BA072A99BQ38275494-B2A87161-B019-4FD4-95D6-CDA53269FA70Q38471014-44059EA9-68FE-4C13-8AFB-CA4AD4223296Q38488118-D891D774-EAD1-466B-9D5D-AE9D12C0CBCAQ38544528-D70C5643-B430-46F1-836A-2E5E389AD145Q40353212-88CF63E6-0841-402D-87C6-EE347BD63291Q40418596-59965C9A-0F39-4B8F-AB54-B5C7422DEFDEQ41117463-C14CB2CE-3526-4034-AC49-D5DB89444083Q41546375-1F2A5A82-2AFD-4573-B6AC-24ED2BED4F38Q41662945-C16C32FA-DA99-4757-B6B0-DEFECA402FE0Q41822249-A76234CE-AD2D-4FDB-881B-2A4E48760371Q42220979-BFB39400-383E-4AEE-8CBC-0FFDBD84BD2AQ43465193-2E17992F-97F4-47EF-925D-53F5B1075577Q44718572-45E42E44-1EC1-454B-B3A8-C05E4D017C14Q47739222-D0374C8D-8FC8-4E68-8718-A2B831E854CF
P2860
Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@ast
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@en
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@nl
type
label
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@ast
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@en
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@nl
prefLabel
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@ast
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@en
Procalcitonin, lipopolysacchar ...... d sepsis: a prospective study.
@nl
P2093
P2860
P921
P356
P1433
P1476
Procalcitonin, lipopolysacchar ...... nd sepsis: a prospective study
@en
P2093
Court Pedersen
Ole Graesbøll Koldkjaer
Svend Stenvang Pedersen
P2860
P2888
P356
10.1186/CC4866
P50
P577
2006-01-01T00:00:00Z
P5875
P6179
1040347570